Video: How AI-driven screening accelerates drug R&D

Archetype CEO Tom Neyarapally spoke with Mika Newton, CEO of xCures, about Archetype's AI driven screening platform. Tom shares how the platform is transforming drug discovery by enabling the rapid screening of billions of molecules and identifying new drugs as well as new uses for existing drugs. This approach integrates patient data with molecular data and generative AI to predict effective treatments for diseases with unmet medical need, significantly reducing the time and cost of drug R&D. Watch the video below.